JP2024099041A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2024099041A5 JP2024099041A5 JP2024073463A JP2024073463A JP2024099041A5 JP 2024099041 A5 JP2024099041 A5 JP 2024099041A5 JP 2024073463 A JP2024073463 A JP 2024073463A JP 2024073463 A JP2024073463 A JP 2024073463A JP 2024099041 A5 JP2024099041 A5 JP 2024099041A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- atom
- acceptable salt
- compound according
- pharmacologically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025203466A JP2026026166A (ja) | 2018-09-06 | 2025-11-26 | 新規環状ジヌクレオチド誘導体及びその抗体薬物コンジュゲート |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2018167369 | 2018-09-06 | ||
| JP2018167369 | 2018-09-06 | ||
| PCT/JP2019/035198 WO2020050406A1 (ja) | 2018-09-06 | 2019-09-06 | 新規環状ジヌクレオチド誘導体及びその抗体薬物コンジュゲート |
| JP2020541321A JP7254818B2 (ja) | 2018-09-06 | 2019-09-06 | 新規環状ジヌクレオチド誘導体及びその抗体薬物コンジュゲート |
| JP2023050936A JP7483975B2 (ja) | 2018-09-06 | 2023-03-28 | 新規環状ジヌクレオチド誘導体及びその抗体薬物コンジュゲート |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023050936A Division JP7483975B2 (ja) | 2018-09-06 | 2023-03-28 | 新規環状ジヌクレオチド誘導体及びその抗体薬物コンジュゲート |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025203466A Division JP2026026166A (ja) | 2018-09-06 | 2025-11-26 | 新規環状ジヌクレオチド誘導体及びその抗体薬物コンジュゲート |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024099041A JP2024099041A (ja) | 2024-07-24 |
| JP2024099041A5 true JP2024099041A5 (cg-RX-API-DMAC7.html) | 2025-01-14 |
Family
ID=69722459
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020541321A Active JP7254818B2 (ja) | 2018-09-06 | 2019-09-06 | 新規環状ジヌクレオチド誘導体及びその抗体薬物コンジュゲート |
| JP2023050936A Active JP7483975B2 (ja) | 2018-09-06 | 2023-03-28 | 新規環状ジヌクレオチド誘導体及びその抗体薬物コンジュゲート |
| JP2024073463A Ceased JP2024099041A (ja) | 2018-09-06 | 2024-04-30 | 新規環状ジヌクレオチド誘導体及びその抗体薬物コンジュゲート |
| JP2025203466A Pending JP2026026166A (ja) | 2018-09-06 | 2025-11-26 | 新規環状ジヌクレオチド誘導体及びその抗体薬物コンジュゲート |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020541321A Active JP7254818B2 (ja) | 2018-09-06 | 2019-09-06 | 新規環状ジヌクレオチド誘導体及びその抗体薬物コンジュゲート |
| JP2023050936A Active JP7483975B2 (ja) | 2018-09-06 | 2023-03-28 | 新規環状ジヌクレオチド誘導体及びその抗体薬物コンジュゲート |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025203466A Pending JP2026026166A (ja) | 2018-09-06 | 2025-11-26 | 新規環状ジヌクレオチド誘導体及びその抗体薬物コンジュゲート |
Country Status (26)
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN118846110A (zh) | 2018-09-06 | 2024-10-29 | 第一三共株式会社 | 抗体药物偶联物 |
| US12678512B2 (en) * | 2020-03-06 | 2026-07-14 | Daiichi Sankyo Company, Limited | Anti-EGFR antibody-drug conjugate with a cyclic dinucleotide derivative |
| US20230141284A1 (en) | 2020-04-10 | 2023-05-11 | Ono Pharmaceutical Co., Ltd. | Cancer therapeutic method |
| EP4209506A4 (en) * | 2020-09-02 | 2024-10-09 | Daiichi Sankyo Company, Limited | NEW ENDO-N-ACETYL GLUCOSAMINIDASE |
| CN116867795A (zh) * | 2021-02-01 | 2023-10-10 | 第一三共株式会社 | 抗体-免疫刺激剂偶联物的新型制造方法 |
| TW202241454A (zh) | 2021-02-01 | 2022-11-01 | 日商第一三共股份有限公司 | 抗體-免疫賦活化劑共軛物之新穎製造方法 |
| JP7721635B2 (ja) | 2021-03-12 | 2025-08-12 | 第一三共株式会社 | 糖鎖及び糖鎖を含む医薬品の製造方法 |
| WO2022226420A2 (en) * | 2021-04-23 | 2022-10-27 | University Of Maryland, College Park | An fc glycan remodeling platform method for site-specific antibody conjugation and applications thereof |
| US20250057967A2 (en) * | 2021-06-25 | 2025-02-20 | Bolt Biotherapeutics, Inc. | Bis-benzimidazole sting agonist immunoconjugates, and uses thereof |
| CA3224492A1 (en) | 2021-07-19 | 2023-01-26 | Xiaojun Han | Immunoconjugates and methods |
| US11806405B1 (en) | 2021-07-19 | 2023-11-07 | Zeno Management, Inc. | Immunoconjugates and methods |
| CN115703845A (zh) * | 2021-08-05 | 2023-02-17 | 中国科学院上海药物研究所 | 寡糖连接子与侧链亲水性片段组合的糖链定点抗体-药物偶联物,其制法及用途 |
| WO2023061405A1 (zh) * | 2021-10-12 | 2023-04-20 | 成都科岭源医药技术有限公司 | 一种高稳定性的靶向接头-药物偶联物 |
| CA3236388A1 (en) | 2021-10-29 | 2023-05-04 | Daiichi Sankyo Company, Limited | Novel oligosaccharide, manufacturing intermediate for novel oligosaccharide, and method for manufacturing these |
| WO2023100829A1 (ja) | 2021-11-30 | 2023-06-08 | 第一三共株式会社 | プロテアーゼ分解性マスク抗体 |
| AU2023218678A1 (en) | 2022-02-09 | 2024-08-01 | Daiichi Sankyo Company, Limited | Environmentally responsive masked antibody and use thereof |
| IL315341A (en) | 2022-03-02 | 2024-10-01 | Daiichi Sankyo Co Ltd | METHOD FOR PRODUCING Fc-CONTAINING MOLECULE |
| JP2025166269A (ja) * | 2022-07-29 | 2025-11-06 | 第一三共株式会社 | 抗腫瘍効果を有する抗体薬物複合体の新規製造方法 |
| KR20250054799A (ko) | 2022-08-29 | 2025-04-23 | 다이이찌 산쿄 가부시키가이샤 | 변이 Fc 영역을 포함하는 항체 약물 콘쥬게이트 |
| KR20250064682A (ko) | 2022-09-09 | 2025-05-09 | 다이이찌 산쿄 가부시키가이샤 | 신규 올리고당, 그 올리고당의 제조 중간체, 및 그것들의 제조 방법 |
| WO2024107827A1 (en) * | 2022-11-16 | 2024-05-23 | The Broad Institute, Inc. | Therapeutic exploitation of sting channel activity |
| EP4626553A2 (en) | 2022-11-30 | 2025-10-08 | Regeneron Pharmaceuticals, Inc. | Tlr7 agonists and antibody-drug-conjugates thereof |
| EP4737483A1 (en) | 2023-06-30 | 2026-05-06 | Daiichi Sankyo Company, Limited | Antibody-drug conjugate production method including purification step using activated carbon material |
| TW202545568A (zh) | 2024-01-29 | 2025-12-01 | 日商第一三共股份有限公司 | 抗her2抗體-藥物結合物與其他劑之組合 |
| TW202543682A (zh) * | 2024-02-28 | 2025-11-16 | 日商第一三共股份有限公司 | 抗cdh6抗體—藥物結合物與其他劑之組合 |
Family Cites Families (64)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3101690B2 (ja) | 1987-03-18 | 2000-10-23 | エス・ビィ・2・インコーポレイテッド | 変性抗体の、または変性抗体に関する改良 |
| IL162181A (en) | 1988-12-28 | 2006-04-10 | Pdl Biopharma Inc | A method of producing humanized immunoglubulin, and polynucleotides encoding the same |
| EP0590058B1 (en) | 1991-06-14 | 2003-11-26 | Genentech, Inc. | HUMANIZED Heregulin ANTIBODy |
| US5885573A (en) | 1993-06-01 | 1999-03-23 | Arch Development Corporation | Methods and materials for modulation of the immunosuppressive activity and toxicity of monoclonal antibodies |
| AU691811B2 (en) | 1993-06-16 | 1998-05-28 | Celltech Therapeutics Limited | Antibodies |
| EP1506285B1 (en) | 2001-11-01 | 2010-12-08 | Uab Research Foundation | Combinations of anti-dr5 antibodies and anti-dr4 antibodies and other therapeutic agents |
| IL149820A0 (en) | 2002-05-23 | 2002-11-10 | Curetech Ltd | Humanized immunomodulatory monoclonal antibodies for the treatment of neoplastic disease or immunodeficiency |
| HUP0600340A3 (en) | 2002-07-15 | 2011-06-28 | Genentech Inc | Methods for identifying tumors that are responsive to treatment with anti-erbb2 antibodies |
| US7662387B2 (en) | 2003-02-20 | 2010-02-16 | Seattle Genetics | Anti-cd70 antibody-drug conjugates and their use for the treatment of cancer and immune disorders |
| CA2647632C (en) | 2006-03-27 | 2017-06-27 | University Of Maryland Biotechnology Institute | Glycoprotein synthesis and remodeling by enzymatic transglycosylation |
| WO2009028639A1 (ja) | 2007-08-30 | 2009-03-05 | Daiichi Sankyo Company, Limited | 抗epha2抗体 |
| JP5566226B2 (ja) | 2009-09-03 | 2014-08-06 | 旭化成株式会社 | 11糖シアリルオリゴ糖ペプチドの製造方法 |
| US9175326B2 (en) | 2011-03-03 | 2015-11-03 | University Of Maryland, Baltimore | Transglycosylation activity of glycosynthase mutants of an endo-beta-N-acetylglucosaminidase (endo-D) from streptococcus pneumoniae |
| US10851174B2 (en) | 2011-03-03 | 2020-12-01 | University Of Maryland, Baltimore | Core fucosylated glycopeptides and glycoproteins: chemoenzymatic synthesis and uses thereof |
| JP6282232B2 (ja) | 2012-02-10 | 2018-02-21 | ユニバーシティー オブ メリーランド,ボルティモア | 抗体及びそのFcフラグメントの酵素化学的糖鎖改変 |
| US10195288B2 (en) | 2012-10-11 | 2019-02-05 | Daiichi Sankyo Company, Limited | Antibody-drug conjugate |
| SG11201502796RA (en) | 2012-12-13 | 2015-05-28 | Aduro Biotech Inc | Compositions comprising cyclic purine dinucleotides having defined stereochemistries and methods for their preparation and use |
| JP2016506408A (ja) | 2012-12-19 | 2016-03-03 | ボード・オブ・リージエンツ,ザ・ユニバーシテイ・オブ・テキサス・システム | 哺乳動物の環状ジヌクレオチドシグナル伝達経路の薬学的標的化 |
| JP2016524593A (ja) | 2013-04-29 | 2016-08-18 | メモリアル スローン−ケタリング キャンサー センター | セカンドメッセンジャーのシグナル伝達を変えるための組成物及び方法 |
| EP2996472B1 (en) | 2013-05-18 | 2019-03-27 | Aduro Biotech, Inc. | Compositions and methods for inhibiting "stimulator of interferon gene" dependent signalling |
| CU24377B1 (es) | 2013-05-18 | 2018-12-05 | Aduro Biotech Inc | Dinucléotidos de purina cíclicos y composiciones de los mismos útiles para inducir la producción de interferón de tipo i dependientes de sting |
| WO2015057065A1 (en) | 2013-10-14 | 2015-04-23 | Synaffix B.V. | Glycoengineered antibody, antibody-conjugate and methods for their preparation |
| WO2015057064A1 (en) | 2013-10-14 | 2015-04-23 | Synaffix B.V. | Modified glycoprotein, protein-conjugate and process for the preparation thereof |
| WO2015057066A1 (en) | 2013-10-14 | 2015-04-23 | Synaffix B.V. | Glycoengineered antibody, antibody-conjugate and methods for their preparation |
| JP2016538877A (ja) | 2013-10-14 | 2016-12-15 | シンアフィックス ビー.ブイ. | 修飾糖タンパク質、タンパク質コンジュゲート及びそれらの調製方法 |
| EP3071229A4 (en) | 2013-11-22 | 2017-05-10 | Brock University | Use of fluorinated cyclic dinucleotides as oral vaccine adjuvants |
| EP3152217B1 (en) | 2014-06-04 | 2018-08-01 | GlaxoSmithKline Intellectual Property Development Limited | Cyclic di-nucleotides as modulators of sting |
| DE102014214408A1 (de) | 2014-07-23 | 2016-01-28 | Wacker Chemie Ag | Härtbare Organopolysiloxanzusammensetzungen |
| PL3608403T3 (pl) | 2014-12-15 | 2025-06-23 | Henkel Ag & Co. Kgaa | Kompozycja detergentowa zawierająca warianty subtylazy |
| US11559581B2 (en) | 2015-01-09 | 2023-01-24 | Oxford University Innovation Limited | Antibody conjugates and methods of making the antibody conjugates |
| TWI706958B (zh) | 2015-03-10 | 2020-10-11 | 美商艾杜諾生物科技公司 | 活化「干擾素基因刺激因子」依賴性訊息傳導之組合物及方法 |
| WO2016161372A1 (en) | 2015-04-01 | 2016-10-06 | President And Fellows Of Harvard College | Immunoconjugates for programming or reprogramming of cells |
| CA2990572C (en) * | 2015-06-29 | 2022-07-26 | Daiichi Sankyo Company, Limited | Method for selectively manufacturing antibody-drug conjugate |
| TWI730972B (zh) | 2015-07-16 | 2021-06-21 | 日商第一三共股份有限公司 | 新穎EndoS變異酵素及使用其之經糖鏈重塑之含Fc區域的分子之製造方法 |
| US10246468B2 (en) | 2015-08-12 | 2019-04-02 | Hoffmann-La Roche Inc. | BACE1 inhibitors |
| CN108137641B (zh) | 2015-08-13 | 2022-04-01 | 默沙东公司 | 作为sting激动剂的环状双核苷酸化合物 |
| US11453697B1 (en) | 2015-08-13 | 2022-09-27 | Merck Sharp & Dohme Llc | Cyclic di-nucleotide compounds as sting agonists |
| KR20180066241A (ko) | 2015-10-28 | 2018-06-18 | 아두로 바이오테크, 인코포레이티드 | “인터페론 유전자의 자극제”-의존성 신호전달을 활성화시키기 위한 조성물 및 방법 |
| CR20180229A (es) * | 2015-10-29 | 2018-08-24 | Novartis Ag | Conjugados de anticuerpos que comprenden un agonista del receptor tipo toll |
| JP6411676B2 (ja) | 2015-12-03 | 2018-10-24 | グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドGlaxosmithkline Intellectual Property Development Limited | Stingの調節因子としての環状プリンジヌクレオチド |
| DE212016000029U1 (de) | 2015-12-07 | 2017-07-30 | Opi Vi - Ip Holdco Llc | Zusammensetzungen von Antikörperkonstrukt-Agonist-Konjugaten |
| US20170158772A1 (en) | 2015-12-07 | 2017-06-08 | Opi Vi - Ip Holdco Llc | Compositions of antibody construct - agonist conjugates and methods of use thereof |
| SMT202500412T1 (it) | 2016-01-11 | 2025-11-10 | Innate Tumor Immunity Inc | Dinucleotidi ciclici per il trattamento di condizioni associate all’attività di sting quali il cancro |
| WO2017123657A1 (en) | 2016-01-11 | 2017-07-20 | Gary Glick | Cyclic dinucleotides for treating conditions associated with sting activity such as cancer |
| IL280430B2 (en) | 2016-03-18 | 2023-11-01 | Univ Texas | Cyclic dinucleotide compounds and methods of use |
| SG10201900628RA (en) | 2016-04-07 | 2019-02-27 | Glaxosmithkline Ip Dev Ltd | Heterocyclic amides useful as protein modulators |
| AU2017246802B2 (en) | 2016-04-07 | 2021-04-01 | Chevron U.S.A. Inc. | Smart gel sealants for well systems |
| US11486223B2 (en) | 2016-04-07 | 2022-11-01 | Chevron U.S.A. Inc. | Method for sealing a void in a well using smart gels |
| WO2017175156A1 (en) | 2016-04-07 | 2017-10-12 | Glaxosmithkline Intellectual Property Development Limited | Heterocyclic amides useful as protein modulators |
| CN109462989A (zh) | 2016-07-01 | 2019-03-12 | 第三共株式会社 | Hanp-含fc分子缀合物 |
| EP3507367A4 (en) | 2016-07-05 | 2020-03-25 | Aduro BioTech, Inc. | CYCLIC DINUCLEOTID COMPOUNDS WITH INCLUDED NUCLEIC ACIDS AND USES THEREOF |
| CA3029644A1 (en) | 2016-07-06 | 2018-01-11 | Sperovie Biosciences, Inc. | Compounds, compositions, and methods for the treatment of disease |
| US20190345191A1 (en) | 2016-08-31 | 2019-11-14 | Innate Tumor Immunity, Inc. | Cyclic dinucleotide analogs for treating conditions associated with sting (stimulator of interferon genes) activity |
| US10537590B2 (en) | 2016-09-30 | 2020-01-21 | Boehringer Ingelheim International Gmbh | Cyclic dinucleotide compounds |
| JP6636673B2 (ja) | 2016-10-04 | 2020-01-29 | メルク・シャープ・アンド・ドーム・コーポレーションMerck Sharp & Dohme Corp. | STINGアゴニストとしてのベンゾ[b]チオフェン化合物 |
| WO2018066626A1 (ja) | 2016-10-07 | 2018-04-12 | 第一三共株式会社 | 抗her2抗体-薬物コンジュゲート投与による耐性癌の治療 |
| WO2018065360A1 (de) | 2016-10-07 | 2018-04-12 | Biolog Life Science Institute Forschungslabor Und Biochemica-Vertrieb Gmbh | Benzimidazolhaltige cyclische dinukleotide, verfahren zu deren herstellung und ihre verwendung zur aktivierung von stimulator von interferongenen (sting)-abhängigen signalwegen |
| JP2018090562A (ja) | 2016-12-01 | 2018-06-14 | 武田薬品工業株式会社 | 環状ジヌクレオチド |
| WO2018100558A2 (en) | 2016-12-01 | 2018-06-07 | Takeda Pharmaceutical Company Limited | Cyclic dinucleotide |
| RU2019122598A (ru) | 2016-12-20 | 2021-01-22 | Мерк Шарп И Доум Корп. | Циклические динуклеотидные агонисты sting для лечения рака |
| CA3049791A1 (en) * | 2017-01-27 | 2018-08-02 | Silverback Therapeutics, Inc. | Tumor targeting conjugates and methods of use thereof |
| TWI926682B (zh) | 2017-05-15 | 2026-05-21 | 日商第一三共股份有限公司 | 抗體-藥物結合物之製造方法 |
| JP6967739B2 (ja) | 2017-11-14 | 2021-11-17 | パナソニックIpマネジメント株式会社 | 給湯機 |
| CN118846110A (zh) | 2018-09-06 | 2024-10-29 | 第一三共株式会社 | 抗体药物偶联物 |
-
2019
- 2019-09-06 CN CN202410810871.3A patent/CN118846110A/zh active Pending
- 2019-09-06 KR KR1020237005621A patent/KR102567591B1/ko active Active
- 2019-09-06 LT LTEPPCT/JP2019/035198T patent/LT3848054T/lt unknown
- 2019-09-06 PL PL19857433.7T patent/PL3848054T3/pl unknown
- 2019-09-06 US US17/273,666 patent/US12370263B2/en active Active
- 2019-09-06 SI SI201930902T patent/SI3848054T1/sl unknown
- 2019-09-06 RS RS20250327A patent/RS66662B1/sr unknown
- 2019-09-06 JP JP2020541321A patent/JP7254818B2/ja active Active
- 2019-09-06 PT PT198574337T patent/PT3848054T/pt unknown
- 2019-09-06 TW TW113138233A patent/TWI905974B/zh active
- 2019-09-06 CA CA3251690A patent/CA3251690A1/en active Pending
- 2019-09-06 ES ES19857433T patent/ES3017008T3/es active Active
- 2019-09-06 IL IL281247A patent/IL281247B2/en unknown
- 2019-09-06 BR BR112021003472-2A patent/BR112021003472A2/pt unknown
- 2019-09-06 CN CN202410810879.XA patent/CN118878620A/zh active Pending
- 2019-09-06 AU AU2019337051A patent/AU2019337051B2/en active Active
- 2019-09-06 KR KR1020257016237A patent/KR20250078590A/ko active Pending
- 2019-09-06 HU HUE19857433A patent/HUE071437T2/hu unknown
- 2019-09-06 DK DK19857433.7T patent/DK3848054T3/da active
- 2019-09-06 CN CN201980058151.3A patent/CN112714649B/zh active Active
- 2019-09-06 EP EP19857433.7A patent/EP3848054B1/en active Active
- 2019-09-06 IL IL315138A patent/IL315138A/en unknown
- 2019-09-06 CA CA3111397A patent/CA3111397C/en active Active
- 2019-09-06 FI FIEP19857433.7T patent/FI3848054T3/fi active
- 2019-09-06 TW TW112114344A patent/TWI861820B/zh active
- 2019-09-06 KR KR1020217009642A patent/KR102567590B1/ko active Active
- 2019-09-06 WO PCT/JP2019/035198 patent/WO2020050406A1/ja not_active Ceased
- 2019-09-06 TW TW108132368A patent/TWI825170B/zh active
- 2019-09-06 SG SG11202101526YA patent/SG11202101526YA/en unknown
- 2019-09-06 HR HRP20250345TT patent/HRP20250345T1/hr unknown
- 2019-09-06 KR KR1020237027378A patent/KR102810513B1/ko active Active
- 2019-09-06 MX MX2021002107A patent/MX2021002107A/es unknown
- 2019-09-06 SM SM20250141T patent/SMT202500141T1/it unknown
- 2019-09-06 EP EP25154566.1A patent/EP4524154A3/en active Pending
-
2021
- 2021-03-02 PH PH12021550442A patent/PH12021550442A1/en unknown
- 2021-03-30 CO CONC2021/0004032A patent/CO2021004032A2/es unknown
-
2023
- 2023-02-27 AU AU2023201159A patent/AU2023201159B2/en active Active
- 2023-03-28 JP JP2023050936A patent/JP7483975B2/ja active Active
-
2024
- 2024-04-22 US US18/642,667 patent/US20240293567A1/en active Pending
- 2024-04-30 JP JP2024073463A patent/JP2024099041A/ja not_active Ceased
-
2025
- 2025-11-26 JP JP2025203466A patent/JP2026026166A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023105175A (ja) | グルクロニド薬物-リンカーの調製のためのプロセスおよびその中間体 | |
| US7968586B2 (en) | Cytotoxic compounds and conjugates | |
| WO2017165851A1 (en) | Process for the preparation of pegylated drug-linkers and intermediates thereof | |
| JP2021523225A5 (cg-RX-API-DMAC7.html) | ||
| US20060247295A1 (en) | Cytotoxic compounds and conjugates with cleavable substrates | |
| WO2018148650A1 (en) | Trigger-activatable sugar conjugates for cancer-selective labeling and targeting | |
| JP2022553702A5 (cg-RX-API-DMAC7.html) | ||
| HRP20250345T1 (hr) | Konjugati antitijelo - lijek derivata cikličnih dinukleotida | |
| KR20080068084A (ko) | 씨씨-1065 유사체를 제조하기 위한 방법 및 화합물 | |
| CN103570792B (zh) | 蟾毒灵衍生物、其制备方法、药物组合物及用途 | |
| JP2006511534A5 (cg-RX-API-DMAC7.html) | ||
| TR201802539T4 (tr) | CC-1065 analoglarının ve bifonksiyonel bağlayıcıların konjugatları. | |
| JP2024532845A5 (cg-RX-API-DMAC7.html) | ||
| PL195014B1 (pl) | Nowe, podstawione pochodne kwasu N-benzyloindol-3-iloglioksylowego o działaniu przeciwnowotworowym oraz ich zastosowanie | |
| CN111417408B (zh) | 药物接头化合物的制备方法 | |
| JP2026507549A (ja) | 改良された特性を有するテトラジン類 | |
| JP5612467B2 (ja) | Fmocをベースとした加水分解性リンカーの調製方法 | |
| KR20180055135A (ko) | 벤조사이아졸 유도체가 결합된 리간드-금속 복합체 및 이의 제조 방법 | |
| JP2022545181A5 (cg-RX-API-DMAC7.html) | ||
| KR20170041562A (ko) | 벤조셀레노펜계 화합물 및 이를 포함하는 항체-약물 결합체 | |
| JP2002533418A (ja) | アントラキノン抗癌剤 | |
| US20250161506A1 (en) | Antibody Drug Conjugate Based on Metal N-Heterocyclic Carbene Complex, a Method of Preparing the Same and the Use of the Same in Anticancer Treatment | |
| JP4590198B2 (ja) | 葉酸誘導体の製造方法 | |
| CN116715678B (zh) | 一种吲哚糖碳苷类大环化合物及其制备方法与应用 | |
| FI3441386T3 (fi) | Menetelmä yksöissuojattujen bifunktionaalisten aihiolääkkeiden syntetisoimiseksi ja niihin perustuvia vasta-aine-lääkekonjugaatteja sekä menetelmä vasta-aine-lääkekonjugaattien valmistamiseksi |